Immunovant, Inc. IMVT Income Tax
Income Tax at other companies
Segments
By geography
See fullOther financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Immunovant, Inc.’s 10-Q, filed February 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s income tax?
- Immunovant, Inc. (IMVT) reported income tax of $1.55M in Q4 2025.
- How has Immunovant, Inc.'s income tax changed year-over-year?
- Immunovant, Inc.'s income tax increased by 921.1% year-over-year, from $152K to $1.55M.
- What is the long-term trend for Immunovant, Inc.'s income tax?
- Over 2 years (2022 to 2025), Immunovant, Inc.'s income tax has grown at a 225.5% compound annual growth rate (CAGR), from -$84K to $890K.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.